Future uncertain for Innate and BMS’ troubled lirilumab
Doubts over future of cancer immunotherapy
X
Future uncertain for Innate and BMS’ troubled lirilumab
https://pharmaphorum.com/news/future-uncertain-innate-bms-troubled-lirilumab/
Innate Pharma
Innate and BMS’ immunotherapy fails in phase 2 trial
French biotech developing cancer immunotherapy with BMS.
Some good news for BMS with Opdivo + natural killer cell combination
But BMS dumps combination with Yervoy.
